Discover how PIMS can work synergistically with your existing Electronic Batch Record (EBR) software and why PIMS is a great alternative.
Requirements to maintain a GxP environment means researchers must conduct software validation on any updated software so it continues to meet users’ needs.
Technology transfer is a necessary evil that exists between drug development and manufacturing. But information sharing is disjointed.
Robust digital workflows in pharma lifecycle management can reduce errors and time to compile data, speeding up regulatory filing.
Mitigating data integrity risks by utilizing cloud-based data management throughout the BioPharma lifecycle
Digital initiatives in BPLM provide an opportunity to modernize legacy processes and replace labor-intensive and time-consuming manual methods.
To bring new therapies to the patients faster, we need to bring people, processes and data together across the full pharma process development lifecycle.
Ensuring product, process and patient data integrity and traceability throughout the BioPharmaceutical lifecycle in the era of personalized medicine
The BioPharma industry is facing a multitude of challenging external trends, from the growth in personalized medicine to supply chain disruptions and more.
IDBS associates had the opportunity to attend some events in Q1 and attendees were eager to see, hear and learn more about what’s happening in the industry.
A digital data backbone is key to a successful instrument data integration, speeding processes so that companies can get their therapies to market faster.
Process digitization for tech transfer in pharma helps reduce risks in data availability and persistence
Accelerating tech transfer is vital with new precision medicine and increasing regulatory scrutiny of product quality and management of external partners.